APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zafirlukas

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Zafirlukas Market Outlook and Growth Opportunities 2026

2 January 2026199 pages

Choose your research edition.

Industry ResearchZafirlukas Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Zafirlukas Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Zafirlukas Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zafirlukas Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Zafirlukas Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Zafirlukas market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Zafirlukas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Zafirlukas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zafirlukas is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Zafirlukas market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Zafirlukas market include Chiesi Farmaceutici, Delta Pharma, Dr Reddys Labs, General Pharma, Hamaz Pharma, Medisure, Par Pharm and Astrazeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Zafirlukas market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Zafirlukas and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zafirlukas sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zafirlukas market size, projected growth trends, production technologies, key applications, and end-use industries.

Zafirlukas Segment by Company

Chiesi Farmaceutici

Delta Pharma

Dr Reddys Labs

General Pharma

Hamaz Pharma

Medisure

Par Pharm

Astrazeneca

Zafirlukas Segment by Type

10mg

20mg

Zafirlukas Segment by Application

Leukotrien Receptor Antagonist

Antiasthmatic Agent

Anti-Inflammatory Agent

Zafirlukas Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Zafirlukas status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Zafirlukas market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Zafirlukas significant trends, drivers, influence factors in global and regions.

6. To analyze Zafirlukas competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zafirlukas market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zafirlukas and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zafirlukas.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zafirlukas market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Zafirlukas industry.

Chapter 3: Detailed analysis of Zafirlukas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Zafirlukas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Zafirlukas in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Zafirlukas Industry Trends Table 2. Zafirlukas Industry Drivers Table 3. Zafirlukas Industry Opportunities and Challenges Table 4. Zafirlukas Industry Restraints Table 5. Global Zafirlukas Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Zafirlukas Revenue Share by Company (2021-2026) Table 7. Global Zafirlukas Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Zafirlukas Sales Volume Share by Company (2021-2026) Table 9. Global Zafirlukas Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Zafirlukas Company Ranking, (2024-2026) & (USD Million) Table 11. Global Zafirlukas Key Company Manufacturing Base & Headquarters Table 12. Global Zafirlukas Company, Product Type & Application Table 13. Global Zafirlukas Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Zafirlukas by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg Table 18. Significant Companies of 20mg Table 19. Global Zafirlukas Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Zafirlukas Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Zafirlukas Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Zafirlukas Sales Volume Share by Type (2021-2026) Table 23. Global Zafirlukas Sales Volume Share by Type (2027-2032) Table 24. Global Zafirlukas Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Zafirlukas Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Zafirlukas Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Zafirlukas Sales Value Share by Type (2021-2026) Table 28. Global Zafirlukas Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Leukotrien Receptor Antagonist Table 30. Significant Companies of Antiasthmatic Agent Table 31. Significant Companies of Anti-Inflammatory Agent Table 32. Global Zafirlukas Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Zafirlukas Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Zafirlukas Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Zafirlukas Sales Volume Share by Application (2021-2026) Table 36. Global Zafirlukas Sales Volume Share by Application (2027-2032) Table 37. Global Zafirlukas Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Zafirlukas Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Zafirlukas Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Zafirlukas Sales Value Share by Application (2021-2026) Table 41. Global Zafirlukas Sales Value Share by Application (2027-2032) Table 42. Global Zafirlukas Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Zafirlukas Sales by Region (2021-2026) & (K Units) Table 44. Global Zafirlukas Sales Market Share by Region (2021-2026) Table 45. Global Zafirlukas Sales by Region (2027-2032) & (K Units) Table 46. Global Zafirlukas Sales Market Share by Region (2027-2032) Table 47. Global Zafirlukas Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Zafirlukas Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Zafirlukas Sales Value Share by Region (2021-2026) Table 50. Global Zafirlukas Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Zafirlukas Sales Value Share by Region (2027-2032) Table 52. Global Zafirlukas Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Zafirlukas Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Zafirlukas Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Zafirlukas Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Zafirlukas Sales by Country (2021-2026) & (K Units) Table 57. Global Zafirlukas Sales Market Share by Country (2021-2026) Table 58. Global Zafirlukas Sales by Country (2027-2032) & (K Units) Table 59. Global Zafirlukas Sales Market Share by Country (2027-2032) Table 60. Global Zafirlukas Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Zafirlukas Sales Value Market Share by Country (2021-2026) Table 62. Global Zafirlukas Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Zafirlukas Sales Value Market Share by Country (2027-2032) Table 64. Chiesi Farmaceutici Company Information Table 65. Chiesi Farmaceutici Business Overview Table 66. Chiesi Farmaceutici Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Chiesi Farmaceutici Zafirlukas Product Portfolio Table 68. Chiesi Farmaceutici Recent Development Table 69. Delta Pharma Company Information Table 70. Delta Pharma Business Overview Table 71. Delta Pharma Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Delta Pharma Zafirlukas Product Portfolio Table 73. Delta Pharma Recent Development Table 74. Dr Reddys Labs Company Information Table 75. Dr Reddys Labs Business Overview Table 76. Dr Reddys Labs Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Dr Reddys Labs Zafirlukas Product Portfolio Table 78. Dr Reddys Labs Recent Development Table 79. General Pharma Company Information Table 80. General Pharma Business Overview Table 81. General Pharma Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. General Pharma Zafirlukas Product Portfolio Table 83. General Pharma Recent Development Table 84. Hamaz Pharma Company Information Table 85. Hamaz Pharma Business Overview Table 86. Hamaz Pharma Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hamaz Pharma Zafirlukas Product Portfolio Table 88. Hamaz Pharma Recent Development Table 89. Medisure Company Information Table 90. Medisure Business Overview Table 91. Medisure Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Medisure Zafirlukas Product Portfolio Table 93. Medisure Recent Development Table 94. Par Pharm Company Information Table 95. Par Pharm Business Overview Table 96. Par Pharm Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Par Pharm Zafirlukas Product Portfolio Table 98. Par Pharm Recent Development Table 99. Astrazeneca Company Information Table 100. Astrazeneca Business Overview Table 101. Astrazeneca Zafirlukas Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Astrazeneca Zafirlukas Product Portfolio Table 103. Astrazeneca Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Zafirlukas Distributors List Table 107. Zafirlukas Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Zafirlukas Product Image Figure 2. Global Zafirlukas Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zafirlukas Sales Value (2021-2032) & (US$ Million) Figure 4. Global Zafirlukas Sales (2021-2032) & (K Units) Figure 5. Global Zafirlukas Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Zafirlukas Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg Image Figure 10. 20mg Image Figure 11. Global Zafirlukas Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Zafirlukas Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Zafirlukas Sales Volume Share by Type (2021-2032) Figure 14. Global Zafirlukas Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Zafirlukas Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Zafirlukas Sales Value Share by Type (2021-2032) Figure 17. Leukotrien Receptor Antagonist Image Figure 18. Antiasthmatic Agent Image Figure 19. Anti-Inflammatory Agent Image Figure 20. Global Zafirlukas Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Zafirlukas Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Zafirlukas Sales Volume Share by Application (2021-2032) Figure 23. Global Zafirlukas Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Zafirlukas Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Zafirlukas Sales Value Share by Application (2021-2032) Figure 26. Global Zafirlukas Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Zafirlukas Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Zafirlukas Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Zafirlukas Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Zafirlukas Sales Value (2021-2032) & (US$ Million) Figure 31. North America Zafirlukas Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Zafirlukas Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Zafirlukas Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Zafirlukas Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Zafirlukas Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Zafirlukas Sales Value (2021-2032) & (US$ Million) Figure 37. South America Zafirlukas Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Zafirlukas Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Zafirlukas Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Zafirlukas Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Zafirlukas Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Zafirlukas Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Zafirlukas Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Zafirlukas Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 20mg
Applications
  • Leukotrien Receptor Antagonist
  • Antiasthmatic Agent
  • Anti-Inflammatory Agent
Companies covered
  • Chiesi Farmaceutici
  • Delta Pharma
  • Dr Reddys Labs
  • General Pharma
  • Hamaz Pharma
  • Medisure
  • Par Pharm
  • Astrazeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zafirlukas Sales Value (2021-2032)
  4. 1.2.2 Global Zafirlukas Sales Volume (2021-2032)
  5. 1.2.3 Global Zafirlukas Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Zafirlukas Market Dynamics
  1. 2.1 Zafirlukas Industry Trends
  2. 2.2 Zafirlukas Industry Drivers
  3. 2.3 Zafirlukas Industry Opportunities and Challenges
  4. 2.4 Zafirlukas Industry Restraints
3 Zafirlukas Market by Company
  1. 3.1 Global Zafirlukas Company Revenue Ranking in 2025
  2. 3.2 Global Zafirlukas Revenue by Company (2021-2026)
  3. 3.3 Global Zafirlukas Sales Volume by Company (2021-2026)
  4. 3.4 Global Zafirlukas Average Price by Company (2021-2026)
  5. 3.5 Global Zafirlukas Company Ranking (2024-2026)
  6. 3.6 Global Zafirlukas Company Manufacturing Base and Headquarters
  7. 3.7 Global Zafirlukas Company Product Type and Application
  8. 3.8 Global Zafirlukas Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Zafirlukas Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Zafirlukas Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Zafirlukas Market by Type
  1. 4.1 Zafirlukas Type Introduction
  2. 4.1.1 10mg
  3. 4.1.2 20mg
  4. 4.2 Global Zafirlukas Sales Volume by Type
  5. 4.2.1 Global Zafirlukas Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zafirlukas Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Zafirlukas Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Zafirlukas Sales Value by Type
  9. 4.3.1 Global Zafirlukas Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zafirlukas Sales Value by Type (2021-2032)
  11. 4.3.3 Global Zafirlukas Sales Value Share by Type (2021-2032)
5 Zafirlukas Market by Application
  1. 5.1 Zafirlukas Application Introduction
  2. 5.1.1 Leukotrien Receptor Antagonist
  3. 5.1.2 Antiasthmatic Agent
  4. 5.1.3 Anti-Inflammatory Agent
  5. 5.2 Global Zafirlukas Sales Volume by Application
  6. 5.2.1 Global Zafirlukas Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Zafirlukas Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Zafirlukas Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Zafirlukas Sales Value by Application
  10. 5.3.1 Global Zafirlukas Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Zafirlukas Sales Value by Application (2021-2032)
  12. 5.3.3 Global Zafirlukas Sales Value Share by Application (2021-2032)
6 Zafirlukas Regional Sales and Value Analysis
  1. 6.1 Global Zafirlukas Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zafirlukas Sales by Region (2021-2032)
  3. 6.2.1 Global Zafirlukas Sales by Region: 2021-2026
  4. 6.2.2 Global Zafirlukas Sales by Region (2027-2032)
  5. 6.3 Global Zafirlukas Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Zafirlukas Sales Value by Region (2021-2032)
  7. 6.4.1 Global Zafirlukas Sales Value by Region: 2021-2026
  8. 6.4.2 Global Zafirlukas Sales Value by Region (2027-2032)
  9. 6.5 Global Zafirlukas Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Zafirlukas Sales Value (2021-2032)
  12. 6.6.2 North America Zafirlukas Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Zafirlukas Sales Value (2021-2032)
  15. 6.7.2 Europe Zafirlukas Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Zafirlukas Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Zafirlukas Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Zafirlukas Sales Value (2021-2032)
  21. 6.9.2 South America Zafirlukas Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Zafirlukas Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Zafirlukas Sales Value Share by Country, 2025 VS 2032
7 Zafirlukas Country-level Sales and Value Analysis
  1. 7.1 Global Zafirlukas Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Zafirlukas Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Zafirlukas Sales by Country (2021-2032)
  4. 7.3.1 Global Zafirlukas Sales by Country (2021-2026)
  5. 7.3.2 Global Zafirlukas Sales by Country (2027-2032)
  6. 7.4 Global Zafirlukas Sales Value by Country (2021-2032)
  7. 7.4.1 Global Zafirlukas Sales Value by Country (2021-2026)
  8. 7.4.2 Global Zafirlukas Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Zafirlukas Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Zafirlukas Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Zafirlukas Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Zafirlukas Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Zafirlukas Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Zafirlukas Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Zafirlukas Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Zafirlukas Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Zafirlukas Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Zafirlukas Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Zafirlukas Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Zafirlukas Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Zafirlukas Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Zafirlukas Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Zafirlukas Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Zafirlukas Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Zafirlukas Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Zafirlukas Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Zafirlukas Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Zafirlukas Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Zafirlukas Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Zafirlukas Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Zafirlukas Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Zafirlukas Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Zafirlukas Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Zafirlukas Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Zafirlukas Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Zafirlukas Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Zafirlukas Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Zafirlukas Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Zafirlukas Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Zafirlukas Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Zafirlukas Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Zafirlukas Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Zafirlukas Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Zafirlukas Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Zafirlukas Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Zafirlukas Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Zafirlukas Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Zafirlukas Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Zafirlukas Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Zafirlukas Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Zafirlukas Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Zafirlukas Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Zafirlukas Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Zafirlukas Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Zafirlukas Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Zafirlukas Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Zafirlukas Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Zafirlukas Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Zafirlukas Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Zafirlukas Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Zafirlukas Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Zafirlukas Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Zafirlukas Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Zafirlukas Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Zafirlukas Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Zafirlukas Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Zafirlukas Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Zafirlukas Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Zafirlukas Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Zafirlukas Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Zafirlukas Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Zafirlukas Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Zafirlukas Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Zafirlukas Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Zafirlukas Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Zafirlukas Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Zafirlukas Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Zafirlukas Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Zafirlukas Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Zafirlukas Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Zafirlukas Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Zafirlukas Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Zafirlukas Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Zafirlukas Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Zafirlukas Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Zafirlukas Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Zafirlukas Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Zafirlukas Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Zafirlukas Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Zafirlukas Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Zafirlukas Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Zafirlukas Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chiesi Farmaceutici
  2. 8.1.1 Chiesi Farmaceutici Company Information
  3. 8.1.2 Chiesi Farmaceutici Business Overview
  4. 8.1.3 Chiesi Farmaceutici Zafirlukas Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chiesi Farmaceutici Zafirlukas Product Portfolio
  6. 8.1.5 Chiesi Farmaceutici Recent Developments
  7. 8.2 Delta Pharma
  8. 8.2.1 Delta Pharma Company Information
  9. 8.2.2 Delta Pharma Business Overview
  10. 8.2.3 Delta Pharma Zafirlukas Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Delta Pharma Zafirlukas Product Portfolio
  12. 8.2.5 Delta Pharma Recent Developments
  13. 8.3 Dr Reddys Labs
  14. 8.3.1 Dr Reddys Labs Company Information
  15. 8.3.2 Dr Reddys Labs Business Overview
  16. 8.3.3 Dr Reddys Labs Zafirlukas Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Dr Reddys Labs Zafirlukas Product Portfolio
  18. 8.3.5 Dr Reddys Labs Recent Developments
  19. 8.4 General Pharma
  20. 8.4.1 General Pharma Company Information
  21. 8.4.2 General Pharma Business Overview
  22. 8.4.3 General Pharma Zafirlukas Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 General Pharma Zafirlukas Product Portfolio
  24. 8.4.5 General Pharma Recent Developments
  25. 8.5 Hamaz Pharma
  26. 8.5.1 Hamaz Pharma Company Information
  27. 8.5.2 Hamaz Pharma Business Overview
  28. 8.5.3 Hamaz Pharma Zafirlukas Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hamaz Pharma Zafirlukas Product Portfolio
  30. 8.5.5 Hamaz Pharma Recent Developments
  31. 8.6 Medisure
  32. 8.6.1 Medisure Company Information
  33. 8.6.2 Medisure Business Overview
  34. 8.6.3 Medisure Zafirlukas Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medisure Zafirlukas Product Portfolio
  36. 8.6.5 Medisure Recent Developments
  37. 8.7 Par Pharm
  38. 8.7.1 Par Pharm Company Information
  39. 8.7.2 Par Pharm Business Overview
  40. 8.7.3 Par Pharm Zafirlukas Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Par Pharm Zafirlukas Product Portfolio
  42. 8.7.5 Par Pharm Recent Developments
  43. 8.8 Astrazeneca
  44. 8.8.1 Astrazeneca Company Information
  45. 8.8.2 Astrazeneca Business Overview
  46. 8.8.3 Astrazeneca Zafirlukas Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Astrazeneca Zafirlukas Product Portfolio
  48. 8.8.5 Astrazeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zafirlukas Value Chain Analysis
  2. 9.1.1 Zafirlukas Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zafirlukas Sales Mode & Process
  6. 9.2 Zafirlukas Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zafirlukas Distributors
  9. 9.2.3 Zafirlukas Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst